Skip to content
BidBenchmark

Contract award

MAPP BIOPHARMACEUTICAL, INC.

DEVELOPMENT OF MEDICAL COUNTERMEASURES THROUGH PLANNED CLINICAL TRIALS AND OUTBREAK PREPAREDNESS
PIID
75A50124C00003
Award key
CONT_AWD_75A50124C00003_7505_-NONE-_-NONE-
Recipient UEI
M9V9QTHR1H28
Source as of
—
Current award value
$5,626,9723
Obligated to date
$5,626,9722
Potential with options
$38,242,6883
Awarding agency
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
Place of performance
San Diego, California
Set-aside
No set-aside used
Pricing
Cost Plus Fixed Fee
Competition
Full and Open Competition1 offers received
Period of performance
Mar 20, 2024 — Dec 31, 2032Through Dec 31, 2032 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Mar 19, 2024Initial award$2,961,209.00$5,626,972.02
P00001Aug 13, 2024M$0.00$5,626,972.02
P00002Oct 1, 2024M$0.00$5,626,972.02
P00003Dec 3, 2024M$0.00$5,626,972.02
P00004Dec 13, 2024M$0.00$5,626,972.02
P00005Jan 13, 2025M$0.00$5,626,972.02
P00006Mar 7, 2025M$0.00$5,626,972.02
P00007Apr 10, 2025M$0.00$5,626,972.02
P00008Apr 22, 2025M$0.00$5,626,972.02
P00009May 28, 2025B$43,289.02$5,626,972.02
P00010Jun 24, 2025M$0.00$5,626,972.02
P00011May 12, 2026M$0.00$5,626,972.02
P00012Aug 12, 2026B$2,622,474.00$5,626,972.02

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.gov—Aug 17, 2026usaspending_contract_csv@2026.08.2f3f79e639fa0
contractor_idUSAspending.gov—Aug 17, 2026usaspending_contract_csv@2026.08.2f3f79e639fa0
current_award_valueUSAspending.gov—Aug 17, 2026usaspending_contract_csv@2026.08.2f3f79e639fa0
naics_codeUSAspending.gov—Aug 17, 2026usaspending_contract_csv@2026.08.2f3f79e639fa0
potential_award_valueUSAspending.gov—Aug 17, 2026usaspending_contract_csv@2026.08.2f3f79e639fa0
psc_codeUSAspending.gov—Aug 17, 2026usaspending_contract_csv@2026.08.2f3f79e639fa0
total_obligatedUSAspending.gov—Aug 17, 2026usaspending_contract_csv@2026.08.2f3f79e639fa0

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 13 transaction records parsed from USAspending.gov, retrieved Aug 17, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
75A50124C00003 — MAPP BIOPHARMACEUTICAL, INC. · BidBenchmark